Literature DB >> 4821905

Influence of thyroid status on plasma half-life of antipyrine in man.

M Eichelbaum, G Bodem, R Gugler, D Schneider-Deters, H J Dengler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4821905     DOI： 10.1056/NEJM197405092901902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

2.  Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease.

Authors:  M Pokrajac; D Simić; V M Varagić
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

6.  Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.

Authors:  J Sonne; S Boesgaard; H E Poulsen; S Loft; J M Hansen; M Døssing; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

7.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Plasma and urinary digoxin in thyroid dysfunction.

Authors:  G M Shenfield; J Thompson; D B Horn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

Review 9.  Drug metabolism in thyroid disease.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.

Authors:  K Tawara; K Kawashima; H Ishikawa; K Yamamoto; K Saito; A Ebihara; S Yoshida
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.